GRCE GRACE THERAPEUTICS INC US FDA Inspections 8-K Filing 2025 - FDA Alignment On April 9, 2025, Grace Therapeutics, Inc. announced its alignment with the FDA for a New Drug Application for GTx-104, a new injectable treatment for aneurysmal subarachnoid hemorrhage.Get access to all SEC 8-K filings of the GRACE THERAPEUTICS INC